Product
Tumor Necrosis Factor Inhibitors
1 clinical trial
1 indication
Indication
Rheumatoid ArthritisClinical trial
Comparative Effectiveness of New Initiators of Tofacitinib and Other Biologic/Targeted Synthetic DMARDs in Patients With Rheumatoid ArthritisStatus: Active (not recruiting), Estimated PCD: 2024-07-15